CONFIRMATORY TESTING RESULTS OF HEPATITIS B VIRUS INFECTION AMONG BLOOD DONORS WITH REACTIVE SCREENING RESULTS AT THE NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION OVER A 5-YEAR PERIOD (2020–2024)

Thị Thanh Dung Nguyễn1, , Vân Chi Trần1, Ngọc Quế Trần1
1 Viện Huyết học – Truyền máu Trung ương

Main Article Content

Abstract

Background: Confirmatory testing accurately determines HBV infection status in blood donors with reactive screening results, enhancing transfusion safety and donor management. Standardizing procedures and post-donation counseling are essential to minimize transmission risk and protect donor rights.


Objective: To determine the true prevalence of HBV infection among blood donors with reactive HBsAg and/or HBV-DNA screening results at the National Institute of Hematology and Blood Transfusion (2020–2024).


Method: A cross-sectional study.


Subjects: 1,922 blood donors with reactive HBV screening results (1,489 HBsAg-reactive, 433 HBV-DNA-reactive) who returned for confirmatory testing after 6 months.


Results: From 2020–2024, among 6,765 donors with reactive HBV screening, 1,922 (28.4%) returned for confirmation. 1,017 (53.0%) were confirmed HBV-infected, including 855 (44.5%) HBsAg-positive and 164 (8.5%) with occult hepatitis B infection (OBI). 697 (36.3%) were HBV-negative, and 206 (10.7%) had indeterminate results requiring follow-up.


Conclusion: Confirmatory testing is crucial to differentiate true infection from false-reactive results, ensuring transfusion safety and supporting appropriate donor counseling and management.

Article Details

References

1. Xuelian Deng, Liang Zang, Xinmei Wang, et al. (2020), Follow-up program for blood donors with unconfirmed screening results reveals a high false-positive rate in Dalian, China. Transfusion, 60(9), 2004-2012.
2. Prashant Pandey, Aseem Kumar Tiwari, Ravi C. Dara, et al. (2015), Confirmation and follow-up of initial “NAT yields”: Prospective study from a tertiary healthcare center in India. Transfusion and Apheresis Science, 54, 242-247.
3. Xuelian Deng, Liang Zang, and Daniel Candotti (2022), Re-Entry Evaluation of Chinese Blood Donors with Unconfirmed Hepatitis B Screening Results. Viruses, 14, 2545.
4. Yuwadee Wanayutthasin, Kamol Suwannakarn, Iyarit Thaipisuttikul, et al. (2019), Confirmation of HBsAg repeatedly reactive in blood donors at Siriraj Hospital. J Hematol Transfus Med, 29, 101-108.
5. Seed CR, Maloney R, Kiely P, et al. (2015), Infectivity of Blood Components From Donors With Occult Hepatitis B Infection – Results From an Australian Look Back Programme. Vox Sang, 108(1), 113-122.
6. Hollinger FB (2008), Hepatitis B Virus Infection and Transfusion Medicine: Science and the Occult. Transfusion, 48(5), 1001-1026.
7. Hoshi Y, Hasegawa T, Yamagishi N, et al. (2009), Optimal Titer of Anti-HBs in Blood Components Derived From Donors With Anti-HBc. Transfusion, 59(8), 2602-2611.
8. Candotti D and Allain JP (2009), Transfusion-transmitted hepatitis B virus infection. J Hepatol, 51(4), 798–809.